Clinical Trials: All items in VIT

17 results

 | 148 Clinical Trials

CTNPT 031: The HAVARTI Trial

Vedolizumab treatment in antiretroviral drug treated chronic HIV infection, followed by analytical treatment interruption (HIV-ART-vedolizumab-ATI)

CTNPT 020: Therapeutic HIV vaccine with early HAART treatment initiation

A pilot randomized, open label study to evaluate the effect of a therapeutic HIV vaccine consisting of PENNVAX®-GP (gag, pol, env) and INO-9012 DNA vaccine delivered via electroporation on reducing HIV viral reservoirs in infected individuals, who initiated therapy during the acute/early phase of infection.

CTNPT 006: The Niaspan® study

Role of extended-released niacin on immune activation in HIV-infected patients treated with antiretroviral therapy: a proof-of-concept study